Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Flumatinib”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Post-approval studies (Phase 4)UnknownNCT04677439
What this trial is testing

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Who this might be right for
FlumatinibChronic Myeloid Leukemia, Chronic PhaseImatinib
Shenzhen Second People's Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT05071482
What this trial is testing

Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL

Who this might be right for
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China 39
Testing effectiveness (Phase 2)UnknownNCT02511340
What this trial is testing

A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients

Who this might be right for
Chronic Myelogenous Leukemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 167
Testing effectiveness (Phase 2)UnknownNCT01503502
What this trial is testing

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Who this might be right for
Myelogenous Leukemia, Chronic
Jiangsu HengRui Medicine Co., Ltd. 150
Early research (Phase 1)Not Yet RecruitingNCT06530810
What this trial is testing

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

Who this might be right for
Chronic Myelogenous LeukemiaCML Chronic PhaseCML Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 100
Post-approval studies (Phase 4)UnknownNCT04933526
What this trial is testing

The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Shenzhen Second People's Hospital 118
Not applicableUnknownNCT04681820
What this trial is testing

Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib

Who this might be right for
CML-CP; Mutation;Suboptimal Response or Failure in TKI
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Large-scale testing (Phase 3)UnknownNCT04375683
What this trial is testing

Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Who this might be right for
Acute Lymphocytic Leukemia, Adult B-CellBCR-ABL1 Fusion Protein Expression
Zhongda Hospital 28
Not applicableUnknownNCT04739826
What this trial is testing

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
CML, Chronic Phase; TKI
The First Affiliated Hospital of Soochow University 491
Large-scale testing (Phase 3)Study completedNCT02204644
What this trial is testing

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

Who this might be right for
CML, CML-CP,MMR,TKI
Jiangsu Hansoh Pharmaceutical Co., Ltd. 400
Not applicableUnknownNCT04591197
What this trial is testing

Flumatinib Efficacy and Safety for New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Validity and Safety
Nanfang Hospital, Southern Medical University 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT05367765
What this trial is testing

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
CML, Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 2,400
Testing effectiveness (Phase 2)Study completedNCT05433532
What this trial is testing

Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

Who this might be right for
Philadelphia ChromosomeAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+2 more
The First Affiliated Hospital of Soochow University 20
Post-approval studies (Phase 4)UnknownNCT05353205
What this trial is testing

The Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Who this might be right for
CML, Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 200